Jay Kailash

Why is Jay Kailash Namkeen Ltd falling/rising?

As of 10-Aug, the stock price of Jay Kailash Namkeen Ltd is at 45.85, down 0.5%. This decline is due to underperformance relative to its sector, a trend reversal after previous gains, and decreased investor participation, despite strong long-term performance.

As of 10-Aug, the stock price of Jay Kailash Namkeen Ltd is currently at 45.85, reflecting a decrease of 0.23 or 0.5%. This decline can be attributed to several factors. <BR><BR>Firstly, the stock has underperformed its sector by 0.54% today, indicating weaker performance relative to its peers. Additionally, after experiencing three consecutive days of gains, the stock has entered a trend reversal, which often signals a shift in market sentiment. <BR><BR>Moreover, there has been a notable decrease in investor participation, with the delivery volume dropping by 7.79% compared to the 5-day average. This decline in trading activity may suggest a lack of confidence among investors, contributing to the downward pressure on the stock price.<BR><BR>Despite these negative indicators, it is worth noting that Jay Kailash Namkeen Ltd has shown strong performance over the past month and year-to-date, with increases of 102.70% and 127.32%, respectively. However, the current price movement reflects a short-term correction following a period of gains, coupled with reduced investor engagement.

Which are the latest news on Jay Kailash?

What does Jay Kailash do?

Jay Kailash Namkeen Ltd is a Micro Cap FMCG company, incorporated in 2021, that acquired the business of 'M/s. Kailash Namkeen.' It currently has no available sales or profit data, with a market cap of INR 23 Cr.

Overview:<BR>Jay Kailash Namkeen Ltd operates in the FMCG sector and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was originally incorporated on June 30, 2021, as "Jay Kailash Namkeen (OPC) Private Limited." It subsequently acquired the ongoing business of the proprietorship firm 'M/s. Kailash Namkeen' via a Business Transfer Agreement dated July 26, 2021, and changed its name to "Jay Kailash Namkeen Private Limited" on May 25, 2022. There is no sales or profit data available for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 23 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 20.00<BR>Industry P/E: 45<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.51<BR>Return on Equity: 6.07%<BR>Price to Book: 1.18<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Jay Kailash?

As of 10th June, Jay Kailash Namkeen Ltd has a market capitalization of 23.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales or Net Profit for the latest four quarters. Shareholder's Funds are 18.50 Cr and Total Assets are valued at 33.35 Cr as of March 2025.

As of 10th June, <BR><BR>Market Cap: Jay Kailash Namkeen Ltd has a market capitalization of 23.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 18.50 Cr and Total Assets valued at 33.35 Cr.

Who are the peers of the Jay Kailash?

Peers of Jay Kailash include Chordia Food, Kanco Tea, Hipolin, KMG Milk Food, Sonalis Consumer, Lake Shore, Novateor Research, Indong Tea Co, Walpar Nutrition, and Tapi Fruit. Sonalis Consumer shows excellent management and growth, while Jay Kailash has below-average ratings in management risk and capital structure, with a 1-year return of -33.11%.

Peers: Chordia Food, Kanco Tea, Hipolin, KMG Milk Food, Sonalis Consumer, Lake Shore, Novateor Resear., Indong Tea Co, Walpar Nutrition, Tapi Fruit.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sonalis Consumer and Walpar Nutrition, while Good management risk is found at Sonalis Consumer and the rest. Below Average management risk is noted at Chordia Food, Kanco Tea, Hipolin, Novateor Resear., Indong Tea Co, and Tapi Fruit, while KMG Milk Food and Lake Shore do not qualify. Growth ratings show Excellent growth at Sonalis Consumer, Average growth at Jay Kailash and Novateor Resear., and Below Average growth at Chordia Food, Kanco Tea, Hipolin, Indong Tea Co, and Tapi Fruit, with KMG Milk Food and Lake Shore not qualifying. Capital Structure ratings indicate Good capital structure at Sonalis Consumer and Walpar Nutrition, while Below Average capital structure is found at Chordia Food, Jay Kailash, Novateor Resear., Indong Tea Co, and Tapi Fruit, with KMG Milk Food and Lake Shore not qualifying.<BR><BR>Return Snapshot: The peer with the highest 1-year return is KMG Milk Food at 10.72%, while Kanco Tea has the lowest at -28.00%. Jay Kailash's 1-year return is -33.11%, which is lower than both. Additionally, peers with negative six-month returns include Kanco Tea, Lake Shore, Indong Tea Co, and Novateor Resear.

Is Jay Kailash overvalued or undervalued?

As of December 3, 2025, Jay Kailash is considered undervalued with a valuation grade upgrade to attractive, featuring a PE ratio of 14.46, an EV to EBITDA ratio of 5.92, and a Price to Book Value of 0.90, especially when compared to peers like Hindustan Unilever and Nestle India, which have much higher PE ratios, despite its recent challenging stock performance with a year-to-date return of -44.69%.

As of 3 December 2025, the valuation grade for Jay Kailash has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, especially when compared to its peers in the FMCG sector. Key ratios include a PE ratio of 14.46, an EV to EBITDA ratio of 5.92, and a Price to Book Value of 0.90, which suggest that the stock is trading at a discount relative to its earnings and book value.<BR><BR>In comparison to its peers, Jay Kailash's valuation stands out, particularly against Hindustan Unilever, which has a PE ratio of 54.52, and Nestle India, with a PE ratio of 79.74, both classified as very expensive. This stark contrast highlights Jay Kailash's potential for growth and value appreciation. Additionally, the company's recent stock performance has been challenging, with a year-to-date return of -44.69%, significantly underperforming the Sensex's 8.92% return, further emphasizing the opportunity for recovery and value realization.

How has been the historical performance of Jay Kailash?

Jay Kailash has shown significant growth over the past three years, with net sales increasing from 9.80 Cr to 15.02 Cr, operating profit rising from 1.29 Cr to 3.76 Cr, and profit after tax growing from 0.89 Cr to 1.21 Cr, indicating improved profitability and financial health. Total assets reached 33.35 Cr, with reserves climbing to 13.50 Cr by Mar'25.

Answer:<BR>The historical performance of Jay Kailash shows significant growth in various financial metrics over the past three years.<BR><BR>Breakdown:<BR>Jay Kailash has demonstrated a strong upward trend in net sales, increasing from 9.80 Cr in Mar'23 to 15.02 Cr in Mar'25. The total operating income followed a similar trajectory, rising from 9.80 Cr to 15.02 Cr during the same period. Despite a decrease in raw material costs, the purchase of finished goods surged, contributing to total expenditure growth from 8.51 Cr in Mar'23 to 11.26 Cr in Mar'25. Operating profit (PBDIT) also improved, reaching 3.76 Cr in Mar'25, up from 1.29 Cr in Mar'23, indicating a healthier operating profit margin that increased from 13.16% to 25.03%. Profit before tax rose from 1.16 Cr in Mar'23 to 1.54 Cr in Mar'25, with profit after tax following suit, increasing from 0.89 Cr to 1.21 Cr. The company's equity capital and reserves have also seen substantial growth, with reserves climbing from 0.70 Cr in Mar'23 to 13.50 Cr in Mar'25. Total assets and liabilities have expanded significantly, with total assets reaching 33.35 Cr and total debt increasing to 13.34 Cr by Mar'25. Cash flow from financing activities has been positive, contributing to a net cash inflow of 2.00 Cr in Mar'25, up from 1.00 Cr in Mar'23. Overall, Jay Kailash's financial performance reflects robust growth and improved profitability over the past three years.

When is the next results date for Jay Kailash?

The next results date for Jay Kailash is 14 November 2025.

The next results date for Jay Kailash is scheduled for 14 November 2025.

Who are the top shareholders of the Jay Kailash?

The top shareholder of Jay Kailash is Neel Narendrabhai Pujara, holding 47.47%, followed by public shareholder Rajdeepsinh Mahipatsinh Chudasama at 9.1%. Individual investors collectively own 47.9% of the shares, with no pledged promoter holdings or involvement from mutual funds or foreign institutional investors.

The top shareholders of Jay Kailash include Neel Narendrabhai Pujara, who holds the largest share at 47.47%. The highest public shareholder is Rajdeepsinh Mahipatsinh Chudasama, with a holding of 9.1%. Additionally, individual investors collectively hold 47.9% of the shares. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors involved.

What is the technical trend for Jay Kailash?

As of June 6, 2025, the market trend is mildly bearish due to daily moving averages and a bearish weekly RSI, despite some bullish signals from the MACD and KST.

As of 6 June 2025, the technical trend has changed from sideways to mildly bearish. The current stance is mildly bearish, with key indicators driving this sentiment being the daily moving averages indicating a bearish trend and the weekly RSI showing bearish momentum. Although the weekly MACD and KST are bullish, the overall trend is influenced by the recent price decline from the previous close and the bearish weekly RSI. The lack of a clear trend in Dow Theory further supports a cautious outlook.

Has Jay Kailash declared dividend?

No Dividend History Available